Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,205 | -26,616 | -27,689 | -35,776 | -4,030 |
| Depreciation Amortization | 1 | 2 | 2 | 2 | 1 |
| Accounts receivable | N/A | 84 | 84 | 25 | 59 |
| Other Working Capital | -280 | -4,756 | -4,991 | -4,999 | 216 |
| Other Operating Activity | 720 | 16,513 | 20,876 | 31,776 | 2,504 |
| Operating Cash Flow | $-3,764 | $-14,773 | $-11,718 | $-8,972 | $-1,250 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | 3,279 | 3,279 | 3,279 | N/A |
| Other Investing Activity | 0 | -3,333 | -3,333 | -2,985 | 0 |
| Investing Cash Flow | $N/A | $-54 | $-54 | $294 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,250 | 1,250 | 1,250 | 1,250 |
| Debt Repayment | -87 | -1,433 | -949 | -285 | -11 |
| Common Stock Issued | N/A | 5,209 | 5,209 | N/A | N/A |
| Common Stock Repurchased | N/A | -99 | -99 | -99 | N/A |
| Other Financing Activity | 0 | 19,682 | 19,752 | 19,752 | -87 |
| Financing Cash Flow | $-87 | $24,609 | $25,163 | $20,618 | $1,152 |
| Beginning Cash Position | 10,521 | 739 | 739 | 739 | 739 |
| End Cash Position | 6,670 | 10,521 | 14,130 | 12,679 | 641 |
| Net Cash Flow | $-3,851 | $9,782 | $13,391 | $11,940 | $-98 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,764 | -14,773 | -11,718 | -8,972 | -1,250 |
| Free Cash Flow | -3,764 | -14,773 | -11,718 | -8,972 | -1,250 |